We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.88T
1-Year Est. Return 44.46%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+0.67%
1 Year Est. Return
+44.46%
3 Year Est. Return
+136.69%
5 Year Est. Return
+180.19%
10 Year Est. Return
+697.06%
AUM
$743B
AUM Growth
+$17B
Cap. Flow
+$20.9B
Cap. Flow %
2.82%
Top 10 Hldgs %
22.73%
Holding
4,944
New
223
Increased
2,961
Reduced
1,210
Closed
86

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$887M
2
AMZN icon
Amazon
AMZN
+$857M
3
AAPL icon
Apple
AAPL
+$844M
4
MSFT icon
Microsoft
MSFT
+$802M
5
TSLA icon
Tesla
TSLA
+$606M

Sector Composition

Rank Sector Weight
1 Technology 24.53%
2 Financials 13.97%
3 Healthcare 13.42%
4 Consumer Discretionary 11.85%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATXS
4001
DELISTED
Astria Therapeutics
ATXS
$535K ﹤0.01%
60,530
+29,063
+92% +$278K
EDUC icon
4002
Educational Development Corp
EDUC
$11.8M
$535K ﹤0.01%
54,899
CZWI icon
4003
Citizens Community Bancorp
CZWI
$203M
$534K ﹤0.01%
38,440
+1,267
+3% +$17.4K
KPRX icon
4004
Kiora Pharmaceuticals
KPRX
$11.4M
$534K ﹤0.01%
660
+619
+1,510% +$526K
VTVT icon
4005
vTv Therapeutics
VTVT
$122M
$531K ﹤0.01%
8,691
+3,786
+77% +$285K
CCLD icon
4006
CareCloud
CCLD
$104M
$530K ﹤0.01%
69,644
MYO icon
4007
Myomo
MYO
$60.6M
$527K ﹤0.01%
44,358
+1,800
+4% +$17.9K
USAU icon
4008
US Gold Corp
USAU
$249M
$527K ﹤0.01%
51,524
AEMD icon
4009
Aethlon Medical
AEMD
$1.54M
$526K ﹤0.01%
34
+8
+31% +$134K
ASX icon
4010
ASE Group
ASX
$105B
$526K ﹤0.01%
67,082
-9,182
-12% -$79.8K
ERF
4011
DELISTED
Enerplus Corporation
ERF
$526K ﹤0.01%
65,754
BIOC
4012
DELISTED
Biocept, Inc.
BIOC
$524K ﹤0.01%
4,358
-137
-3% -$16K
ONCS
4013
DELISTED
OncoSec Medical Incorporated
ONCS
$521K ﹤0.01%
11,137
+2,804
+34% +$142K
UAMY icon
4014
United States Antimony
UAMY
$793M
$517K ﹤0.01%
571,454
+10,279
+2% +$9.46K
CLIR icon
4015
ClearSign Technologies
CLIR
$28.6M
$515K ﹤0.01%
25,791
-187
-0.7% -$6.26K
GPGI
4016
GPGI Inc
GPGI
$3.84B
$514K ﹤0.01%
61,291
DTST icon
4017
Data Storage Corp
DTST
$8.04M
$514K ﹤0.01%
+115,968
New +$582K
FWAC
4018
DELISTED
Fifth Wall Acquisition Corp. III Class A Ordinary Shares
FWAC
$513K ﹤0.01%
52,330
DGNU
4019
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$512K ﹤0.01%
52,306
EH
4020
EHang Holdings
EH
$437M
$509K ﹤0.01%
21,304
-2,606
-11% -$71K
ISSC icon
4021
Innovative Solutions & Support
ISSC
$391M
$507K ﹤0.01%
70,974
+5,460
+8% +$38K
CEMI
4022
DELISTED
Chembio diagnostics, Inc.
CEMI
$507K ﹤0.01%
203,070
+58,448
+40% +$162K
JILL icon
4023
J. Jill
JILL
$281M
$504K ﹤0.01%
29,046
+1,183
+4% +$23.5K
CGRN
4024
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$501K ﹤0.01%
104,221
+28,479
+38% +$133K
INUV icon
4025
Inuvo
INUV
$14.4M
$500K ﹤0.01%
71,546

Similar funds

Geode Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
  • Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
  • Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
  • Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
  • Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
  • Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
  • Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.

Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.